About: In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic "gray zone" of total PSA 4 to 10 ng/mL

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic "gray zone" of total PSA 4 to 10 ng/mL Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 September 1998

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у вересні 1998 (uk) im September 1998 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en setiembre de 1998 (ast) scientific article published on 01 September 1998 (en)
publication date	wds:Q77214815-3FCBF265-4CE0-4DFA-AB4C-1FA1A24462CD
publication date	1998-09-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q77214815-9ED73181-8641-4E9F-B4CB-F9CD5A7DADEA
language of work or name	English
cites work	wds:Q77214815-0349A1EF-5140-4B26-B56B-E988D2A9B4C9 wds:Q77214815-05A6FEC2-512B-4CB8-A58E-DB460F562921 wds:Q77214815-0AB6197C-8683-4F5E-83AC-F63C0A595EEA wds:Q77214815-3CF636C3-EBAC-403F-AE32-C82A7CECAD80 wds:Q77214815-5D520765-92D8-4DCC-846B-BE12A473B8C6 wds:Q77214815-6AE03CD6-B2A2-4F32-A8F1-F2B939D104F0 wds:Q77214815-A3B7A088-9029-4F8F-B5A7-9D2CD54C8C7C wds:Q77214815-A4989A34-D504-499B-A9A8-3FFB58412D03 wds:Q77214815-B0183EE1-A8E5-482F-9C0F-05A99316E57A wds:Q77214815-B18F732E-D79F-4BA1-8E8C-E12CFD48109B wds:Q77214815-B8FF0AEE-FA28-46FA-90DF-B1C12101D9FD wds:Q77214815-BAA8DCB4-EFB9-463F-B91B-A71532449A77 wds:Q77214815-BEA46429-4E15-461C-8B97-18F2ADFB437A wds:Q77214815-D1344A0C-7377-478D-B294-9BA350B4F416 wds:Q77214815-DEF8838B-9052-4747-9287-F78EF12F0F61 wds:Q77214815-F7D99C08-2636-4A01-8DD9-E5456F7D51C5 wds:Q77214815-FB035C16-C986-498C-A0CB-E2C1DC352259
cites work	The glandular kallikrein family of enzymes: tissue-specific expression and hormonal regulation Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker NONPROSTATIC SOURCES OF PROSTATE-SPECIFIC ANTIGEN Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate cDNA coding for the entire human prostate specific antigen shows high homologies to the human tissue kallikrein genes The meaning and use of the area under a receiver operating characteristic (ROC) curve Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era. Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors High level of expression in the prostate of a human glandular kallikrein mRNA related to prostate-specific antigen Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease Activation of the zymogen form of prostate-specific antigen by human glandular kallikrein 2. Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer Tissue-specific and hormonal regulation of human prostate-specific glandular kallikrein The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen Expression of the gene coding for human prostate-specific antigen and related hGK-1 in benign and malignant tumors of the human prostate Impact of free prostate-specific antigen on discordant measurement results of assays for total prostate-specific antigen
author name string	wds:Q77214815-084B9394-0AF8-4735-A299-110B1330B336 wds:Q77214815-1BACE52D-5BFD-4AB7-A73E-59F0E6677F08 wds:Q77214815-2DDBB811-F8C6-42A4-827D-5C0B05F99622 wds:Q77214815-3BDE40A0-3B85-4A7E-A164-F52A4EC447E6 wds:Q77214815-97D09C00-9E3F-49E2-9A14-B3C724B2CA20 wds:Q77214815-9F28C57B-D611-47B6-9801-33C4FA18BAF1 wds:Q77214815-E9254870-CD3F-4A9B-8038-217F1FAECBE8
author name string	K Pettersson F Recker M Wernli T Otto T Piironen M K Kwiatkowski R Tscholl
rdfs:label	In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic "gray zone" of total PSA 4 to 10 ng/mL (en) In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic "gray zone" of total PSA 4 to 10 ng/mL (nl)
skos:prefLabel	In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic "gray zone" of total PSA 4 to 10 ng/mL (en) In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic "gray zone" of total PSA 4 to 10 ng/mL (nl)
name	In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic "gray zone" of total PSA 4 to 10 ng/mL (en) In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic "gray zone" of total PSA 4 to 10 ng/mL (nl)
title	wds:Q77214815-38237272-2CF8-4171-9981-9128D0BDD950
title	In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic "gray zone" of total PSA 4 to 10 ng/mL (en)
page(s)	wds:Q77214815-C60644D2-1DE5-4A8C-9FD2-40ACA81DAF99
page(s)	360-365
instance of	wds:Q77214815-73D9D110-812D-48EC-AC7C-DF61DB9C531F
instance of	scholarly article
main subject	wds:Q77214815-FED9612E-92AD-43DA-99A9-CEEF219EDED4
main subject	prostate cancer
PubMed ID	wds:Q77214815-33FC69D1-ED39-432F-AFB2-FDDEF472318A
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9730444
PubMed ID	9730444
published in	wds:Q77214815-79A857A8-7C62-48EB-BDC2-8BDE969124FD
published in	Urology
issue	wds:Q77214815-969D21E7-83FB-4A9A-A5C0-59D61E575DD4
volume	wds:Q77214815-1924C1F4-B857-4895-88E2-E05F51C8BD59
issue	3
volume	52
DOI	wds:Q77214815-027FE821-AD14-4698-8683-B510523BA793
DOI	http://dx.doi.org/10.1016/S0090-4295(98)00245-3
DOI	10.1016/S0090-4295(98)00245-3
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q77214815
is cites work of	Differential steroid hormone regulation of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) in breast cancer cell lines Prostate-specific antigen, its molecular forms, and other kallikrein markers for detection of prostate cancer Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues Novel diagnostic biomarkers for prostate cancer Tumor markers in prostate cancer I: blood-based markers Tumor markers: an update on human kallikrein 2. Human glandular kallikrein as a tool to improve discrimination of poorly differentiated and non-organ-confined prostate cancer compared with prostate-specific antigen Human kallikrein gene 13 (KLK13) expression by quantitative RT-PCR: an independent indicator of favourable prognosis in breast cancer Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissue Multivariate gene expression analysis reveals functional connectivity changes between normal/tumoral prostates Lowering PSA cutoffs to enhance detection of curable prostate cancer Molecular markers of prostate cancer Use of human glandular kallikrein 2 for the detection of prostate cancer: preliminary analysis Emerging PSA-based tests to improve screening Kallikreins as biomarkers for prostate cancer

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software